Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001693198-17-000001
Filing Date
2017-01-23
Accepted
2017-01-23 15:42:53
Documents
1
Effectiveness Date
2017-01-23
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 7486
  Complete submission text file 0001693198-17-000001.txt   8472
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-585-2000
Goldfinch BioPharma, Inc. (Filer) CIK: 0001693198 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: D | Act: 33 | File No.: 021-279008 | Film No.: 17541013